Research ExplorerJournalsBREAST CANCER-TOKYO Publications

BREAST CANCER-TOKYO - Breast cancer (Tokyo, Japan)

1 - 3 out of 3Page size: 50

Publications

  1. 2023

  2. Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies

    Yamamoto, Y., Yamashiro, H., Schneeweiss, A., Müller, V., Gluz, O., Klare, P., Aktas, B., Magdolna, D., Büdi, L., Pikó, B., Mangel, L., Toi, M., Morita, S. & Ohno, S., 01.2023, In: BREAST CANCER-TOKYO. 30, 1, p. 88-100 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2022

  4. 6q deletion is frequent but unrelated to patient prognosis in breast cancer

    Lebok, P., Bönte, H., Kluth, M., Möller-Koop, C., Witzel, I., Wölber, L., Paluchowski, P., Wilke, C., Heilenkötter, U., Müller, V., Schmalfeldt, B., Simon, R., Sauter, G., Terracciano, L., Krech, R. H., von der Assen, A. & Burandt, E., 03.2022, In: BREAST CANCER-TOKYO. 29, 2, p. 216-223 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2016

  6. Cyclin D1 gene amplification is highly homogeneous in breast cancer

    Burandt, E., Grünert, M., Lebeau, A., Choschzick, M., Quaas, A., Jänicke, F., Müller, V., Scholz, U., Bokemeyer, C., Petersen, C., Geist, S., Paluchowski, P., Wilke, C., Heilenkötter, U., Simon, R., Sauter, G. & Wilczak, W., 01.2016, In: BREAST CANCER-TOKYO. 23, 1, p. 111-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review